Selected Publications

Academic Article

Year Title Altmetric
2016 The effects of differences in pspA alleles and capsular types on the resistance of Streptococcus pneumoniae to killing by apolactoferrin.Microbial Pathogenesis.  99:209-219. 2016
2016 Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine Production.Clinical and Diagnostic Laboratory Immunology.  23:681-688. 2016
2016 Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile.BMC Microbiology.  16:5. 2016
2015 Discovery and Characterization of Human-Urine Utilization by Asymptomatic-Bacteriuria-Causing Streptococcus agalactiae.Infection and Immunity.  84:307-319. 2015
2015 Loss of Vancomycin-Resistant Enterococcus Fecal Dominance in an Organ Transplant Patient With Clostridium difficile Colitis After Fecal Microbiota Transplant.Open Forum Infectious Diseases.  2:ofv078. 2015
2014 Copper complexation screen reveals compounds with potent antibiotic properties against methicillin-resistant Staphylococcus aureus.Antimicrobial Agents and Chemotherapy.  58:3727-3736. 2014
2013 Asymptomatic bacteriuria: prevalence rates of causal microorganisms, etiology of infection in different patient populations, and recent advances in molecular detection.FEMS Microbiology Letters.  346:1-10. 2013
2013 Erratum: Diversity of group B streptococcus serotypes causing urinary tract infection in adults (Journal of Clinical Microbiology (2009) 47:7 (2055-2060))Journal of Clinical Microbiology.  51:2806. 2013
2012 Prognostic value of semi-quantitative bacteruria counts in the diagnosis of group B streptococcus urinary tract infection: a 4-year retrospective study in adult patients.BMC Infectious Diseases.  12:273. 2012
2012 Device for carrying blood samples at 37°C for cryoglobulin test.Clinical and Diagnostic Laboratory Immunology.  19:1555-1556. 2012
2012 Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.Infection and Immunity.  80:3145-3160. 2012
2012 Group B streptococcus cystitis presenting in a diabetic patient with a massive abdominopelvic abscess: a case report.Journal of Medical Case Reports.  6:237. 2012
2011 Development of an automated and multiplexed serotyping assay for Streptococcus pneumoniae.Clinical and Diagnostic Laboratory Immunology.  18:1900-1907. 2011
2011 Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin.Infection and Immunity.  79:2440-2450. 2011
2010 Hit-and-run stimulation: a novel concept to reactivate latent HIV-1 infection without cytokine gene induction.Journal of Virology.  84:8712-8720. 2010
2010 Group B Streptococcus (GBS) urinary tract infection involves binding of GBS to bladder uroepithelium and potent but GBS-specific induction of interleukin 1alpha.Journal of Infectious Diseases.  201:866-870. 2010
2009 Diversity of group B streptococcus serotypes causing urinary tract infection in adults.Journal of Clinical Microbiology.  47:2055-2060. 2009
2008 PIR-B-deficient mice are susceptible to Salmonella infection.Journal of Immunology.  181:4229-4239. 2008
2006 Risk of infection and tracking of work-related infectious diseases in the funeral industry.American Journal of Infection Control.  34:655-660. 2006
2006 Case report: Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O motherAnnals of Clinical and Laboratory Science.  36:205-207. 2006
2006 Validation of a multiplex pneumococcal serotyping assay with clinical samples.Journal of Clinical Microbiology.  44:383-388. 2006
2005 Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae.Vaccine.  23:4257-4262. 2005
2005 Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae.Emerging Infectious Diseases.  11:814-820. 2005
2005 Long-term molecular analysis of tuberculosis strains in alabama, a state characterized by a largely indigenous, low-risk population.Journal of Clinical Microbiology.  43:870-878. 2005
2005 Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activityJournal of Clinical Investigation.  115:66-75. 2005
2005 Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies.Journal of Clinical Microbiology.  43:156-162. 2005
2004 Erratum: PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin (Infection and Immunity (2004) 72, 9 (5031-5040))Infection and Immunity.  72:7379. 2004
2004 Lipoprotein PsaA in virulence of Streptococcus pneumoniae: surface accessibility and role in protection from superoxide.Infection and Immunity.  72:5858-5867. 2004
2004 PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected].Infection and Immunity.  72:5031-5040. 2004
2003 Dissemination of macrolide-resistant Streptococcus pneumoniae isolates containing both erm(B) and mef(A) in South Korea.Journal of Clinical Microbiology.  41:5787-5791. 2003
2003 Evaluation of an extensive tuberculosis contact investigation in an urban community and jail.International Journal of Tuberculosis and Lung Disease.  7:S417-S423. 2003
2003 The rapid development of fluoroquinolone resistance in M. tuberculosis.New England Journal of Medicine.  349:1977-1978. 2003
2003 Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.Journal of Infectious Diseases.  188:339-348. 2003
2003 Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.Clinical and Diagnostic Laboratory Immunology.  10:514-519. 2003
2003 Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.Journal of Clinical Microbiology.  41:2458-2464. 2003
2003 Vancomycin-resistant enterococci: 15 years and counting.Journal of Hospital Infection.  53:159-171. 2003
2003 Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.Microbial Drug Resistance.  9 Suppl 1:S69-S77. 2003
2003 Ligase chain reaction.Methods in Molecular Biology.  226:135-150. 2003
2002 Evidence for Epstein-Barr virus autoantibodies against human brain in demyelinating encephalitis.Neuropathology and Applied Neurobiology.  28:498-501. 2002
2002 Cross-jurisdictional transmission of Mycobacterium tuberculosis in Maryland and Washington, D C, 1996-2000, linked to the homeless.Emerging Infectious Diseases.  8:1249-1251. 2002
2002 Molecular differentiation of Mycobacterium tuberculosis strains without IS6110 insertions.Emerging Infectious Diseases.  8:1310-1313. 2002
2002 Molecular epidemiology of tuberculosis in a low- to moderate-incidence state: are contact investigations enough?Emerging Infectious Diseases.  8:1271-1279. 2002
2002 Molecular epidemiology of tuberculosis in a sentinel surveillance population.Emerging Infectious Diseases.  8:1197-1209. 2002
2002 Molecular typing of Mycobacterium tuberculosis strains with a common two-band IS6110 pattern.Emerging Infectious Diseases.  8:1303-1305. 2002
2002 Expression, autoregulation, and DNA binding properties of the Mycobacterium tuberculosis TrcR response regulator.Journal of Bacteriology.  184:2192-2203. 2002
2001 In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children.International Journal of Antimicrobial Agents.  18:531-535. 2001
2001 Value of Mycobacterium tuberculosis fingerprinting as a tool in a rural state surveillance program.Chest.  120:1877-1882. 2001
2001 Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes.International Journal of Antimicrobial Agents.  18:373-378. 2001
2001 Epidemiologic usefulness of spoligotyping for secondary typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110.Journal of Clinical Microbiology.  39:3709-3711. 2001
2001 Identification of a contaminating Mycobacterium tuberculosis strain with a transposition of an IS6110 insertion element resulting in an altered spoligotype.Journal of Clinical Microbiology.  39:1092-1096. 2001
2001 Direct identification of Mycobacterium avium complex and Mycobacterium gordonae from MB/BacT bottles using AccuProbe.Journal of Clinical Microbiology.  39:570-573. 2001
2000 Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice.Infection and Immunity.  68:5652-5656. 2000
2000 The MB/BacT is a sensitive method of isolating Mycobacterium tuberculosis from clinical specimens in a laboratory with a low rate of isolation.Journal of Clinical Microbiology.  38:3133-3134. 2000
2000 Use of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children.Journal of Clinical Microbiology.  38:1731-1734. 2000
1999 Comparison of direct inoculation and Copan transport systems for isolation of Neisseria gonorrhoeae from endocervical specimens.Journal of Clinical Microbiology.  37:3583-3585. 1999
1999 Spot sputum screening: evaluation of an intervention in two homeless shelters.International Journal of Tuberculosis and Lung Disease.  3:613-619. 1999
1999 In vitro evidence of two-component system phosphorylation between the Mycobacterium tuberculosis TrcR/TrcS proteins.Microbial Pathogenesis.  26:195-206. 1999
1998 Comparison of the MB/BacT system with a revised antibiotic supplement kit to the BACTEC 460 system for detection of mycobacteria in clinical specimens.Journal of Clinical Microbiology.  36:3234-3238. 1998
1998 Restriction fragment length polymorphism screening of Mycobacterium tuberculosis isolates: population surveillance for targeting disease transmission in a community.International Journal of Tuberculosis and Lung Disease.  2:655-662. 1998
1997 Avirulence of LT2 strains of Salmonella typhimurium results from a defective rpoS gene.Infection and Immunity.  65:2451-2453. 1997
1997 Bacterial phenotypes mediated by mviA and their relationship to the mouse virulence of Salmonella typhimurium.Microbial Pathogenesis.  22:353-362. 1997
1996 Transmission of mycobacterium tuberculosis to recipients of single lung transplants from the same donorPneumologie.  50:733. 1996
1996 Immunoprotection by monoclonal antibodies to the porins and lipopolysaccharide of Salmonella typhimurium.Microbial Pathogenesis.  21:249-263. 1996
1996 The predicted amino acid sequence of the Salmonella typhimurium virulence gene mviAA(+) strongly indicates that MviA is a regulator protein of a previously unknown S. typhimurium response regulator family.Infection and Immunity.  64:2365-2367. 1996
1996 Acid shock induction of RpoS is mediated by the mouse virulence gene mviA of Salmonella typhimurium.Journal of Bacteriology.  178:2572-2579. 1996
1996 Transmission of Mycobacterium tuberculosis to recipients of single lung transplants from the same donor.American Journal of Respiratory and Critical Care Medicine.  153:1166-1168. 1996
1995 Laboratory contamination of Mycobacterium tuberculosis cultures.American Journal of Respiratory and Critical Care Medicine.  152:1702-1704. 1995
1994 Mouse virulence gene A (mviA+) is a pleiotropic regulator of gene expression in Salmonella typhimurium.Annals of the New York Academy of Sciences.  730:295-296. 1994
1994 The intracellular nature of Salmonella infection during the early stages of mouse typhoid.Immunology series.  60:303-312. 1994
1993 In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activity.Cancer Research.  53:2810-2815. 1993
1992 A 'safe-site' for Salmonella typhimurium is within splenic polymorphonuclear cells.Microbial Pathogenesis.  13:181-190. 1992
1992 Detection of DNA in Southern blots by chemiluminescence is a sensitive and rapid technique.BioTechniques.  12:836-838. 1992
1992 In vivo administration of bryostatin 1, a protein kinase C activator, decreases murine resistance to Salmonella typhimurium.Cancer Research.  52:2143-2147. 1992
1991 The Salmonella typhimurium locus mviA regulates virulence in Itys but not Ityr mice: functional mviA results in avirulence; mutant (nonfunctional) mviA results in virulence.Journal of Experimental Medicine.  174:1073-1083. 1991
1991 A hemA mutation renders Salmonella typhimurium avirulent in mice, yet capable of eliciting protection against intravenous infection with S. typhimurium.Microbial Pathogenesis.  11:289-295. 1991
1991 A 'safe-site' for Salmonella typhimurium is within splenic cells during the early phase of infection in mice.Microbial Pathogenesis.  10:297-310. 1991
1991 Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growth.Infection and Immunity.  59:852-856. 1991
1990 The primary effect of the Ity locus is on the rate of growth of Salmonella typhimurium that are relatively protected from killing.Journal of Immunology.  144:3143-3151. 1990
1989 Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.Infection and Immunity.  57:1457-1464. 1989
1989 Modulation of resistance to Salmonella typhimurium infection in mice by mouse hepatitis virus (MHV).Microbial Pathogenesis.  6:81-91. 1989
1986 Effects of in vitro growth phase on the pathogenesis of Salmonella typhimurium in mice.Journal of general microbiology.  132:1283-1295. 1986
1986 Genetic mapping of novel virulence determinants of Salmonella typhimurium to the region between trpD and supD.Microbial Pathogenesis.  1:115-124. 1986
1986 Salmonella typhimurium virulence genes necessary to exploit the Itys/s genotype of the mouse.Infection and Immunity.  51:872-878. 1986
1986 Independence of macrophage activation and expression of the alleles of the Ity (immunity to typhimurium) locus.Microbial Pathogenesis.  1:33-41. 1986
1986 Genetic approaches to the study of disease resistance: with special emphasis on the use of recombinant inbred mice.Current Topics in Microbiology and Immunology.  124:21-35. 1986
1986 Genetic control of the susceptibility to pneumococcal infection.Current Topics in Microbiology and Immunology.  124:103-120. 1986
1985 Induction of germ-line anti-alpha 1-3 dextran antibody responses in mice by members of the Enterobacteriaceae family.Journal of Immunology.  135:3468-3472. 1985
1985 The ability of Salmonella typhimurium to produce the siderophore enterobactin is not a virulence factor in mouse typhoid.Infection and Immunity.  50:392-397. 1985
1984 Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia.Journal of Immunology.  133:3308-3312. 1984
1981 A genetic locus responsible for salmonella susceptibility in BSVS mice is not responsible for the limited T-dependent immune responsiveness of BSVS mice.Journal of Immunology.  127:906-911. 1981

Research Overview

  • Clinical parasitology in Alabama, investigating zoonotic parasites that can infect humans. Diagnostic Mycobacteriology, mainly decreasing time to diagnosis of Mycobacterial infections
  • Education And Training

  • Doctor of Philosophy in Microbiology, University of Alabama at Birmingham
  • Full Name

  • William Benjamin
  • Blazerid

  • bbenjami